Compare SRRK & PCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRRK | PCTY |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.1B |
| IPO Year | 2018 | 2014 |
| Metric | SRRK | PCTY |
|---|---|---|
| Price | $49.35 | $99.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 17 |
| Target Price | $56.17 | ★ $176.59 |
| AVG Volume (30 Days) | ★ 1.1M | 674.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.74 |
| EPS | N/A | ★ 3.81 |
| Revenue | N/A | ★ $1,595,221,000.00 |
| Revenue This Year | N/A | $11.52 |
| Revenue Next Year | $534.24 | $7.98 |
| P/E Ratio | ★ N/A | $26.52 |
| Revenue Growth | N/A | ★ 13.74 |
| 52 Week Low | $27.07 | $92.99 |
| 52 Week High | $52.19 | $197.78 |
| Indicator | SRRK | PCTY |
|---|---|---|
| Relative Strength Index (RSI) | 59.72 | 34.40 |
| Support Level | $45.46 | $92.99 |
| Resistance Level | $51.55 | $117.32 |
| Average True Range (ATR) | 2.07 | 4.06 |
| MACD | 0.38 | -1.79 |
| Stochastic Oscillator | 92.50 | 2.12 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Paylocity is a cloud-based human capital management provider offering payroll, compliance, and human resources management solutions. With the addition of expense and IT management modules, Paylocity unifies back-office operations spanning HR, finance, and IT on a single platform and bills customers on a subscription basis. The firm's customer base skews toward the midmarket and is primarily based in the US. As of fiscal 2025, Paylocity has nearly 42,000 customers.